These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34520983)

  • 41. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
    Gray RG; Quirke P; Handley K; Lopatin M; Magill L; Baehner FL; Beaumont C; Clark-Langone KM; Yoshizawa CN; Lee M; Watson D; Shak S; Kerr DJ
    J Clin Oncol; 2011 Dec; 29(35):4611-9. PubMed ID: 22067390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
    Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D
    J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
    Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
    Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma.
    Wang Q; Cheng N; Li X; Pan H; Li C; Ren S; Su C; Cai W; Zhao C; Zhang L; Zhou C
    Oncotarget; 2017 Jan; 8(2):2558-2567. PubMed ID: 27911863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non-coding ribonucleic acid H19 and ten-eleven translocation enzyme 1 messenger RNA expression levels in uterine fibroids may predict their postoperative recurrence.
    Zhan X; Zhou H; Sun Y; Shen B; Chou D
    Clinics (Sao Paulo); 2021; 76():e2671. PubMed ID: 34644730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer.
    Malakorn S; Ouchi A; Hu CY; Sandhu L; Dasari A; You YN; Kopetz ES; Ellis LM; Chang GJ
    Clin Colorectal Cancer; 2021 Mar; 20(1):e53-e60. PubMed ID: 33004292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.
    Zhou H; Shen W; Zou H; Lv Q; Shao P
    J Int Med Res; 2020 Jul; 48(7):300060520934297. PubMed ID: 32660285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
    Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
    J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Radial Margin Positivity With Colon Cancer.
    Amri R; Bordeianou LG; Sylla P; Berger DL
    JAMA Surg; 2015 Sep; 150(9):890-8. PubMed ID: 26132363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
    Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
    J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
    Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
    Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients.
    Zhou M; Zhong L; Xu W; Sun Y; Zhang Z; Zhao H; Yang L; Sun J
    Sci Rep; 2016 Aug; 6():31038. PubMed ID: 27503456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A stroma-related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early-stage colon cancer.
    Zhou R; Sun H; Zheng S; Zhang J; Zeng D; Wu J; Huang Z; Rong X; Bin J; Liao Y; Shi M; Liao W
    J Cell Mol Med; 2020 Mar; 24(5):3229-3241. PubMed ID: 31989761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer.
    Wu ZH; Wang XL; Tang HM; Jiang T; Chen J; Lu S; Qiu GQ; Peng ZH; Yan DW
    Oncol Rep; 2014 Jul; 32(1):395-402. PubMed ID: 24840737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
    Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
    Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis.
    Liu J; Zhan Y; Wang J; Wang J; Guo J; Kong D
    Mol Oncol; 2020 Dec; 14(12):3211-3233. PubMed ID: 33040438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.